Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Bio-Rad Laboratories's enterprise value was $8.69B on Oct 19, 2026, against $8.71B a year earlier. Over the last 5 years it ranged from $5.91B to $21.49B, with a median of $9.28B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $8.69B | +6.9% |
| 2025 | Dec 31, 2025 | $8.12B | -8.9% |
| 2024 | Dec 31, 2024 | $8.92B | -0.6% |
| 2023 | Dec 29, 2023 | $8.97B | -24.9% |
| 2022 | Dec 30, 2022 | $11.93B | -44.5% |
| 2021 | Dec 31, 2021 | $21.49B | +30.7% |
| 2020 | Dec 31, 2020 | $16.44B | +55.3% |
| 2019 | Dec 31, 2019 | $10.59B | +60.6% |
| 2018 | Dec 31, 2018 | $6.59B | -4.0% |
| 2017 | Dec 29, 2017 | $6.86B | +36.8% |
| 2016 | Dec 30, 2016 | $5.02B | +35.0% |
| 2015 | Dec 31, 2015 | $3.72B | +14.8% |
| 2014 | Dec 31, 2014 | $3.24B | -5.5% |
| 2013 | Dec 31, 2013 | $3.43B | +19.0% |
| 2012 | Dec 31, 2012 | $2.88B | +13.0% |
| 2011 | Dec 30, 2011 | $2.55B | -12.6% |
| 2010 | Dec 31, 2010 | $2.92B | +18.5% |
| 2009 | Dec 31, 2009 | $2.46B | – |